Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @KidneydrChirag
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KidneydrChirag
-
In this editorial, we discuss management of creatinine elevations (??AKI) with intensive BP regimen to achieve SPRINT goals. Majority of creatinine rise not associated with injury- it is permissive hypercreatininemia. Algorithm below. Let us know your thoughts.https://twitter.com/nephrokarger/status/1224282128717877248 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chirag Parikh proslijedio/la je Tweet
Permissive AKI in the treatment of heart failure ca. 2019 from
@Kidney_Int@scoca1@KidneydrChirag#Nephpearls#Cardiorenal
https://www.kidney-international.org/article/S0085-2538(19)30708-2/fulltext …pic.twitter.com/EKZqHWt0uy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chirag Parikh proslijedio/la je Tweet
This is a great finding! Especially in the era of
#advancingkidneyhealthhttps://twitter.com/KidneydrChirag/status/1215023428241149952 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Huge Variation in recovery and transplant of deceased donor AKI kidneys....pic.twitter.com/gpEQj9mtGz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In the propensity matched analysis of deceased donors, kidneys with AKI have similar outcomes as non-AKI kidneys. Also, large variation across transplant centers utilizing AKI kidneys. Great opportunity to expand deceased donor pool with AKI kidneys.
@renalgal@hopkinsnephhttps://twitter.com/JAMANetworkOpen/status/1215000221484298240 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enjoyed developing this editorial with
@StevenMenez. Lots of unanswered questions and opportunities to optimize RAAS inhibition in the setting of AKI- we believe majority of the bumps in creatinine are not intrinsic kidney injury.https://twitter.com/CJASN/status/1210259245406597127 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chirag Parikh proslijedio/la je Tweet
Nice work
@StevenMenez! Renin-Angiotension System Blockade after Acute Kidney Injuryhttps://cjasn.asnjournals.org/content/early/2019/12/15/CJN.13801119 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations! Although only 10 years old, the consortium has uplifted the landscape of kidney disease knowledge with its immense contributions.
@JHUWelchCenter@JoeCoresh@meg21212@hopkinsnephhttps://twitter.com/alexchangmd/status/1194760636783308804 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations, to
@stephensozio@DrDeidraCrews@DuvuruG@hopkinsneph for this wonderful achievement and for many years of hard work to enhance education and knowledge on kidney diseases.pic.twitter.com/xz7HAy8vyu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chirag Parikh proslijedio/la je Tweet
Newly established ‘mid-career’ awards
@SusanQuaggin announcing the awards@jaykoyner@DuvuruG@DrDeidraCrews @dwein003@LaurenceHBeckJ1@stephensozio Tamara Isikova of@NU_Nephrology and more Congrats to all the awardees!#KidneyWkpic.twitter.com/v0IJiLTktd
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chirag Parikh proslijedio/la je Tweet
Academic Nephrology Opportunity at Johns Hopkins/Baltimore job with Johns Hopkins University School of Medicine, Div of Nephrology Baltimore, Maryland https://www.nejmcareercenter.org/job/298211/academic-nephrology-opportunity-at-johns-hopkins-baltimore/?TrackID=3713 …
#jobsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If donor quality had a huge role in recipient outcomes, the kidney pairs from same donor in two recipients should have correlated outcomes. We saw only minimal concordance in donor pairs after rigorous testing. Can we justify discarding >3000 kidneys/year on donor quality?https://twitter.com/CJASN/status/1190660141735120897 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fenofibrates joins other agents such as ACE/ARBs, SGLT2 inhibitors, etc where biomarkers help clarify that bumps in creatinine are not due to injury to the kidney.https://twitter.com/hswapnil/status/1182089925723734021 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enjoyed developing the editorial with
@scoca1 . We hope more patients can get cardioprotective medications. “Permissive AKI” with treatment of heart failurehttps://www.sciencedirect.com/science/article/pii/S0085253819307082 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you for inviting me. Had a great time meeting everyone at UVA
@UVANeph@MarkOkusahttps://twitter.com/KalantariMD/status/1182788427709853696 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Clinical trials in contrast nephropathy require 6000-10,000 patients as outcomes of doubling, dialysis and death are rare. We show that biomarkers of injury can enrich the event rates and reduce the trial size by 30-40%! Huge cost savings!https://twitter.com/AJKDonline/status/1178619249931296769 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@StevenMenez and the @KPMProject investigators finalizing the AKI adjudication protocol before the first AKI biopsypic.twitter.com/tBDDa4e0TR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Yes-the challenge is to determine the Rolle’s point on the curve- the inflection point-when compensation ends and decompensation starts (in medicine) or more taxation will reduce revenue in economy. There is a Rolle’s point for every organ and every economy!https://twitter.com/methodsmanmd/status/1172126292336087041 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As classification, diagnostic criteria and pathogenic theories have evolved since the traditional description of HRS-1 and HRS-2, we have summarized novel aspects and new classification framework for hepatorenal syndrome in this position paper.
@ggarciatsao@ProfPaoloAngelihttps://twitter.com/QxMD/status/1171544001100558337 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
By linking 7 datasets, 10 year longitudinal follow-up of 3600 children after surgical repair for CHD demonstrates good progress but we can do better to reduce incidence of ESKD and mortality. Maybe better control of hypertension?
@JasonHenryG@ChanchlaniRahulhttps://twitter.com/CJASN/status/1171468596268023809 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Teresa K. Chen